← Evidence map

ArticleUrology2012

Re: Twardowski et al.: Phase II study of aflibercept (VEGF-Trap) in patients with recurrent or metastatic urothelial cancer: a California Cancer Consortium Trial (Urology 2010;76:923-926).

Przemyslaw TwardowskiPubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Re: Twardowski et al.: Phase II study of aflibercept (VEGF-Trap) in patients with recurrent or metastatic urothelial cancer: a California Cancer Consortium Trial (Urology 2010;76:923-926). | OpenQuestion